Accelerate Diagnostics, Inc. is an in vitro diagnostics (IVD) company dedicated to developing and commercializing rapid diagnostic solutions for serious infections, including sepsis. Their core focus is on significantly reducing the time to pathogen identification and antimicrobial susceptibility testing (AST) compared to traditional laboratory methods. The company's flagship platform, the Accelerate Pheno® system and Accelerate PhenoTest® BC kit, aims to provide clinicians with actionable results in hours, enabling faster, more informed treatment decisions for critically ill patients. This approach seeks to improve patient outcomes, optimize antibiotic stewardship, reduce healthcare costs, and help combat the global crisis of antimicrobial resistance.
The Tucson headquarters serves as the primary center for corporate leadership, research and development, manufacturing of its diagnostic instruments and consumables, global marketing, and administrative operations.
The facility houses advanced research and development laboratories for diagnostic innovation, specialized manufacturing areas for the Pheno™ system and test kits, and corporate offices. It is equipped to support the entire lifecycle of their products from conception to market.
The work culture at Accelerate Diagnostics is likely driven by a strong sense of purpose, focusing on innovation, scientific excellence, collaboration, and a commitment to improving patient care. Employees are mission-oriented, aiming to make a significant impact in the fight against life-threatening infections.
This headquarters is crucial as it's the nerve center for all strategic, operational, R&D, and manufacturing activities. Its location in Tucson leverages local talent and the supportive biotech ecosystem in Arizona.
Accelerate Diagnostics maintains a global presence primarily through its U.S. headquarters in Tucson, Arizona, and its European commercial hub in Germany. Beyond these direct offices, the company extends its reach through a network of distributors and commercial partners in various countries across Europe, Asia-Pacific, the Middle East, and Latin America. This network supports global sales, customer installations, technical service, and clinical support for their diagnostic systems.
3950 S. Country Club Rd., Suite 160
Tucson
AZ
USA
Address: Max-Eyth-Straße 38/1, 71088 Holzgerlingen, Germany
To expand market presence and adoption of Accelerate Diagnostics' rapid testing solutions across Europe, manage regional distribution channels, navigate European regulatory requirements, and provide localized support to enhance customer experience and patient outcomes in the EMEA market.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Accelerate Diagnostics' leadership includes:
Accelerate Diagnostics has been backed by several prominent investors over the years, including:
Over the past year, Accelerate Diagnostics solidified its financial leadership with the formal appointment of its Chief Financial Officer, following a prior departure in the role. These changes reflect the company's ongoing efforts to strengthen its executive team for strategic execution.
Discover the tools Accelerate Diagnostics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Accelerate Diagnostics commonly utilizes an email format consisting of the first initial of the employee's first name followed by their full last name, preceding the '@acceleratedx.com' domain. This is a standard professional email structure.
flast@acceleratedx.com
Format
jphillips@acceleratedx.com
Example
85%
Success rate
GlobeNewswire • 2024-05-08
Accelerate Diagnostics reported its financial results for the first quarter of 2024, providing updates on revenue, operational progress, and strategic initiatives related to its rapid diagnostic platforms for infectious diseases....more
GlobeNewswire • 2024-02-29
The company released its financial performance for the fourth quarter and full fiscal year 2023, discussing key achievements, challenges, and the ongoing commercialization efforts for its sepsis and antibiotic resistance testing solutions....more
GlobeNewswire • 2023-11-08
Accelerate Diagnostics shared its third-quarter 2023 financial outcomes, highlighting commercial activities, research advancements, and its market outlook in the rapid diagnostics sector....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Accelerate Diagnostics, are just a search away.